Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Medizinische Klinik (Munich, Germany : 1983)|August 21, 2003
[Suspected cases of severe side effects after infliximab (Remicade) in Germany]Tilo Andus, Eduard F Stange, Dieter Höffler, et al.International Journal of Medical Microbiology : IJMM|October 24, 2009
Innate antimicrobial host defense in small intestinal Crohn's diseaseMaureen J Koslowski, Julia Beisner, Eduard F Stange, et al.European Journal of Gastroenterology & Hepatology|July 4, 2003
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann, Jan Wehkamp, Klaus R Herrlinger, et al.The Biochemical Journal|January 23, 2002
Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant miceOliver Müller, Carmen Schalla, Jürgen Scheibner, et al.Journal of Lipid Research|May 13, 2008
Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone diseaseOlga Renner, Simone Harsch, André Strohmeyer, et al.Antimicrobial Agents and Chemotherapy|July 16, 2014
Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficileSabine Nuding, Tina Frasch, Martin Schaller, et al.Inflammatory Bowel Diseases|October 9, 2004
Fatal staphylococcal sepsis in Crohn's disease after infliximabKlaus R Herrlinger, Annette Borutta, Gabriel Meinhardt, et al.Antimicrobial Agents and Chemotherapy|July 24, 2013
Antimicrobial activity of high-mobility-group box 2: a new function to a well-known proteinRobert Küchler, Bjoern O Schroeder, Simon U Jaeger, et al.United European Gastroenterology Journal|November 1, 2014
Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individualsOlga Renner, Simone Harsch, Silke Matysik, et al.Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of disease: defensins in gastrointestinal diseasesJan Wehkamp, Klaus Fellermann, Klaus R Herrlinger, et al.Pageof 11